Insiders who reported open-market trades in the last 12 months at the companies Samraat S. Raha files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
S. Louise Phanstiel - $495K in MYGN purchases and sales in the last 12 months
Rashmi Kumar - $67K in MYGN purchases and sales in the last 12 months
Paul Bisaro - $28K in MYGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Samraat S. Raha is a corporate insider, tracked as President and CEO, Director of MYRIAD GENETICS INC (MYGN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Samraat S. Raha last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 5 filings going back to 2024.
Has Samraat S. Raha been buying or selling stock?
Recorded transactions: 1 open-market purchase ($200K) and 0 open-market sales across all tracked filings.
Samraat S. Raha is President and CEO, Director of MYRIAD GENETICS INC (MYGN). 5 SEC Form 4 filings on record going back to 2024, most recently on 12 June 2026. Most recent open-market trade: bought $200K of MYGN on 9 March 2026. Lifetime open-market purchases: $200K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Samraat S. Raha.
InsiderAlpha's records for Samraat S. Raha go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $200K (1 buy totaling $200K). The largest single buy on record is $200K of MYGN in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
